Kangmei Pharma | 600518 - 债务利息支出

金融业

CNY

CNY 13.31B

现金及等价物

CNY 1.23B

CNY 841.45M

CNY 6.8B

CNY 5.38B

CNY 173.71M

CNY -12.72M

CNY -12.72M

6.37K

EPS每股收益

CNY 0

股本和储备

CNY 7.31B

CNY 238.34M

债务利息支出

CNY 1.82M

CNY 2.44M

CNY 68.57M

CNY 18.85B

CNY -16.56M

CNY 1.09B

CNY -10.94M

普通股股本

CNY 13.83B

1.11K

CNY -14.01M

CNY 1.08B

销售和管理费用

CNY 237.06M

CNY 2.38B

贸易债权人

CNY 2.46B

应收帐款人

CNY 2.92B

	债务利息支出	更改		日
Akebia Therapeutics	362.52M		357.69M	2026-03
Alaunos Therapeutics	USD 1.07M		215K	2023-06
Avita Medical	AUD 1.25M		100K	2025-06
Cspc Pharmaceutical	CNY 6.76M		3.43M	2025-12
Dianthus Therapeutics	USD 4.44M		263K	2024-09
Genomma Lab Internacional	MXN 190.68M		972K	2025-12
Hypermarcas	BRL 36.54M		3.75M	2025-12
Ionis Pharmaceuticals	USD 18M		1000K	2026-06
IQVIA Holdings	USD 192M		1000K	2026-03
Jiangsu Hengrui	CNY 254.59M		253.85M	2025-09
Kangmei Pharma	CNY 1.82M		150K	2025-09
Moderna	USD 10.96B		527M	2026-06
Organon & Co	USD 111M		17M	2026-03
Revvity	USD 24.72M		1.2M	2026-03
Sh Fosun Pharma	CNY 321.25M		2M	2025-09
Tectonic Therapeutic	USD 246.58M		246.56M	2026-03
Viatris	USD 120.1M		500K	2026-03
Wuxi Apptec	CNY 103.05M		37.29M	2025-06
Xeris Pharmaceuticals	USD 6.88M		269K	2026-03
Zz Pientze Pharmaceu	CNY 46.05M		36.5M	2025-06